🚀 iConnect powers the RECOVER study TrialX iConnect is proud to support RECOVER (Researching COVID to Enhance Recovery), a nationwide initiative dedicated to understanding, treating, and preventing Long COVID. Our award winning patient recruitment management system will help…
This year’s SCOPE was amazing and well attended with over 3100 people coming from around the globe representing sponsors, CROs, suppliers, consultants and most importantly patients. Coming off last year where there was a fraction of…
This year’s SCOPE was amazing and well attended with over 3100 people coming from around the globe representing sponsors, CROs, suppliers, consultants and most importantly patients. Coming off last year where there was a fraction of…
👨🏻‍💼FROM THE CEO’s DESK “As we wrap up 2022, we are pleased to see 12 million+ actions taken by patients, researchers and study sponsors across all our platforms to support clinical research. This includes hundreds of…
Space health research may have broad applicability for conducting DCT on earth. We had a very exciting and informative webinar on Nov 9, 2022 – the first in our Space Health & DCT Webinar Series –…
This September, as we all await the successful launch of Artemis 1, we at TrialX are gearing up to demo how we are enabling decentralized clinical research in commercial space missions at the Mobile Tech in…
Ability to re-use and integrate research data across research studies (with appropriate consents) has the potential to unlock innovative and actionable insights. The TrialX xPand system enables collection of diverse types of data including surveys with…